We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Axcella Health Inc | NASDAQ:AXLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.58 | 4.50 | 4.51 | 0 | 01:00:00 |
FORM 3
| Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Nestle Health Science US Holdings, Inc. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
| 3. Issuer Name and Ticker or Trading Symbol Axcella Health Inc. [AXLA] |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___X___ 10% Owner _____ Officer (give title below) _____ Other (specify below) | ||
5. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned | |||
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 2368699 | I | See Footnote (1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks: This Form 3 is being filed late due to administrative oversight. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Nestle Health Science US Holdings, Inc. 1812 NORTH MOORE STREET ARLINGTON, VA 22209 | X | ||||
Societe des Produits Nestle S.A. AVENUE NESTLE 55, CH-1800 VEVEY, V8 | X | ||||
Nestle US Holdco, Inc. 1812 NORTH MOORE STREET ARLINGTON 22209 | X | ||||
NESTLE SA AVENUE NESTLE 55, CH-1800 VEVEY | X | ||||
NIMCO US, Inc. 1812 NORTH MOORE STREET ARLINGTON, VA 22209 | X |
Signatures | ||
NESTLE HEALTH SCIENCE US HOLDINGS, INC. By: Name: James Pepin, Title: Director and President | 2/12/2020 | |
**Signature of Reporting Person | Date | |
NIMCO US, INC. By: Name: Dan Nugent, Title: Chief Legal Officer and General Counsel | 2/12/2020 | |
**Signature of Reporting Person | Date | |
NESTLE US HOLDCO, INC. By: Name: Michael Prewitt, Title: Secretary | 2/12/2020 | |
**Signature of Reporting Person | Date | |
SOCIETE DES PRODUITS NESTLE S.A. By: Name: Claudio Kuoni, Title: Vice President | 2/12/2020 | |
**Signature of Reporting Person | Date | |
NESTLE S.A. By: Name: Gregory Behar, Title: Deputy Executive Vice President | 2/12/2020 | |
**Signature of Reporting Person | Date |
1 Year Axcella Health Chart |
1 Month Axcella Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions